Literature DB >> 8468241

BMS-181184, a new pradimicin derivative. Screening, taxonomy, directed biosynthesis, isolation and characterization.

T Furumai1, K Saitoh, M Kakushima, S Yamamoto, K Suzuki, C Ikeda, S Kobaru, M Hatori, T Oki.   

Abstract

BMS-181184 is a new semisynthetic pradimicin derivative with a broad-spectrum antifungal activity. In a search for actinomycetes producing BMS-181184, 4 strains of Actinomadura sp. isolated from soil samples were found to produce the antibiotic under conditions of directed biosynthesis. Among them, Actinomadura sp. AB1236 proved most useful in the production of BMS-181184 when fermented in a medium containing D-serine and D-cycloserine. A minor product isolated from the broth of strain AB1236 was identified as the dexylosyl analog of BMS-181184, which was also obtained by acid hydrolysis of BMS-181184.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468241     DOI: 10.7164/antibiotics.46.265

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.

Authors:  C E Gonzalez; A H Groll; N Giri; D Shetty; I Al-Mohsen; T Sein; E Feuerstein; J Bacher; S Piscitelli; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 3.  Pradimicins: a novel class of broad-spectrum antifungal compounds.

Authors:  T J Walsh; N Giri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

4.  Carbohydrate-Binding Non-Peptidic Pradimicins for the Treatment of Acute Sleeping Sickness in Murine Models.

Authors:  Víctor M Castillo-Acosta; Luis M Ruiz-Pérez; Juan Etxebarria; Niels C Reichardt; Miguel Navarro; Yasuhiro Igarashi; Sandra Liekens; Jan Balzarini; Dolores González-Pacanowska
Journal:  PLoS Pathog       Date:  2016-09-23       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.